Eijgenraam, Tim R.
Boukens, Bastiaan J.
Boogerd, Cornelis J.
Schouten, E. Marloes
van de Kolk, Cees W. A.
Stege, Nienke M.
te Rijdt, Wouter P.
Hoorntje, Edgar T.
van der Zwaag, Paul A.
van Rooij, Eva
van Tintelen, J. Peter
van den Berg, Maarten P.
van der Meer, Peter
van der Velden, Jolanda
Silljé, Herman H. W.
de Boer, Rudolf A.
Article History
Received: 28 January 2020
Accepted: 26 May 2020
First Online: 17 June 2020
Change Date: 2 October 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: The University Medical Center Groningen, which employs the majority of the authors, has received research grants and/or fees from Abbott, AstraZeneca, Bristol-Myers Squibb, Novartis, Novo Nordisk, and Roche. R.A.d.B. is a minority shareholder of scPharmaceuticals, and received personal fees from Abbott, AstraZeneca, MandalMed. and Novartis. The other authors have no competing interests.